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Abstract
Background: The plasminogen activator inhibitor-1 (PAI-1), which modulates fibrinolysis and cell migration, may influence
proteolysis and neointimal formation in the arterial wall contributing to restenosis after vascular injury. Antioxidants have been proposed
as inhibiting multiple proatherogenic events. We explore the effect of vitamins C and E on PAI-1 expression in an experimental model of
angioplasty in hypercholesterolemic pigs. Methods and results: A total of 44 Yucatan minipigs were divided into three diet groups: a
normal-cholesterol (NC), a high-cholesterol (HC), and a high-cholesterol plus vitamins C1E (HCV) group. Balloon injury was induced
in the right internal iliac artery 4 weeks after initiation of either dietary regimen, and plasma and tissue samples were taken at different
time periods to measure PAI-1 activity and vascular inhibitor expression. The cholesterol-rich diet induced an increased in vascular PAI-1
expression in the intima, media and adventitia which was markedly reduced in the HCV group. After injury, severe structural changes
were observed in NC and HC animals associated with increased systemic PAI-1 activity (P,0.001) and local PAI-1 expression being
more intense in HC group. Vitamins C and E significantly reduced plasma PAI-1 activity (P50.018) and attenuated the inhibitor
expression as compared with HC. Conclusions: This experimental study in a porcine model of hypercholesterolemia demonstrates that
vitamins C and E reduce local and systemic PAI-1 induced after angioplasty as well as the hypercholesterolemia-induced vascular PAI-1.
Ó 2001 Elsevier Science B.V. All rights reserved.
Keywords: Atherosclerosis; Cholesterol; Angioplasty; Hemostasis; Restenosis
1. Introduction An injury-related healing response mediated by smooth
muscle cell (SMC) proliferation and neointima formation,
Percutaneous angioplasty is an established treatment for leading to luminal narrowing, has been considered an
atherothrombosis. Despite a primary success rate, angio- essential factor in the development of late restenosis.
plasty induces early reocclusion in 3–13% and late re- Recent data also indicate that vascular remodeling is an
stenosis in more than 30% of patients treated. The mecha- important pathophysiological mechanism for restenosis [4–
nisms promoting these lesions are not completely under- 7].
stood and different pharmacological strategies have not The plasminogen activator /plasmin system has been
proved effective in preventing these complications al- implicated in several cardiovascular disorders, including
though the introduction of intracoronary stents has reduced wound healing after vascular reconstruction as suggested
their incidence in recent years [1–3]. from data obtained in PAI-1 knockout mice [8,9]. Recent
observations indicate that components of this system may
influence the process of restenosis by either promoting or
´*Corresponding author. Present address: Clınica Universitaria, Servicio inhibiting the development of the neointima [10–12]. PAI-
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1, the primary physiological inhibitor of plasminogen leaving left internal iliac arteries as control. A total of four
activators, is an important determinant of fibrinolysis at animals from NC and HC groups were sacrificed at days 3,
sites of vascular injury and has been implicated in the 7, 14 and 28 after the first intervention with a lethal dose
pathogenesis of thrombosis at the arterial site [13,14]. of 65 mg/kg pentobarbital (Sigma, USA) followed by a
Clinical studies have suggested a relationship between bolus of KCl. Experiments were not performed at day 3 in
PAI-1 in plasma and cardiovascular risk [15–17], and it the HCV group (total number included512) based on the
has also been reported that the levels of PAI-1 mRNA are unlikely short-term effect of the treatment.
significantly elevated in atherosclerotic vessels and corre-
late with the severity of atherosclerotic lesions [14,18–20]. 2.3. Arterial injury
Antioxidant vitamins C and E have been evaluated
through clinical studies for their effect on the prevention Each animal was fasted overnight before the day of the
and treatment of atherosclerotic disease, although there is study but allowed ad libitum access to tap water. Animals
controversy surrounding the results [21]. At the ex- were sedated, intubated and ventilated through an endotra-
perimental level, treatment with antioxidants has been cheal tube. Anesthetic induction was completed by i.v.
shown to reduce intimal lesions after injury in hyper- injection of 2 mg/kg metomidate (Esteve Veterinaria,
cholesterolemic animals [22,23] and may contribute to Spain); 0.2 mg/ l pancuronium bromide (Organon, The
plaque stabilization [24], but its possible effect on the Netherlands) and 0.05 mg fentanyl (Roche, Switzerland)
regulation of fibrinolysis has not been properly assessed. were given to maintain a constant level of anesthesia. The
We therefore tried to analyze the local and systemic right internal jugular vein and carotid artery were exposed
changes of PAI-1 in an experimental model of angioplasty by cutdown and cannulated with a 7F venous sheath and
induced in hypercholesterolemic pigs, on the basis they 9F arterial sheath, respectively.
would likely predispose to thrombosis and possibly re- After iliac angiography, endothelial injury was per-
stenosis [25]. We tested further the hypothesis that vita- formed by three 30-s inflations of a balloon catheter at 8
mins C and E would favorably alter vascular PAI-1 atm, separated by 30-s intervals, in the medial portion of
expression induced by hypercholesterolemia and mechani- the internal iliac artery. The balloon diameter was chosen
cal injury in this experimental model. in order to achieve a balloon/artery diameter rate higher
than 1.2.
Arterial blood samples were drawn before and after
2. Methods injury for analytical measurements and vascular tissues
were obtained for histological purposes.
2.1. Animals
2.4. Tissue processing
A total of 44 Yucatan minipigs (4 months old, mean
weight 33.2961.69 kg), procured from our breeding The iliac arterial tree was dissected, perfused with 4%
center, were maintained in the animal facilities of CIFA paraformaldehyde at 48C for 10 min and left in 500 ml of
(GLP accredited center at the University of Navarra, 4% paraformaldehyde at 48C for 4 h. Arteries were cut to
Spain) in accordance with the Guide for the Care and Use 1-cm-long pieces and paraffin embedded (up to eight
of Laboratory Animals published by US National Institutes pieces per block). Serial sections were cut (5 mm) for in
of Health (NIH Publication No. 85-23, revised 1996). situ hybridization (ISH) and immunohistochemistry, and
mounted on microscope slides (ProbeOn Plus, Fisher-
2.2. Hypercholesterolemic model Scientific, USA). Adjacent sections were stained with
hematoxylin-eosin or elastin (van Giesson) for morphomet-
Animals were divided into three groups and fed on ric studies. Sections with maximal lesion were chosen for
different dietary formulations for 4 weeks: a normal- analysis.
cholesterol (NC) control group (n516), fed standard
porcine chow (Porcisanders, Sanders, Spain); a high- 2.5. Morphometric analysis
cholesterol (HC) group (n516) fed with a diet containing
24.5% animal lard, 4% cholesterol (Roig Farma, Spain) Stained arterial sections were examined with a micro-
and 1.5% bile extract (Roig Farma, Spain); and a high- scope (Nikon Optiphot-2, Japan). Images were acquired
cholesterol plus vitamins C and E (HCV) group (n512) with a video camera (Sony DX-151 AP, Japan) attached to
fed in the same way as HC group but supplemented during a computer, and analyzed with Optimas 5.2 (Media
the final week with 1 g vitamin C and 1000 IU vitamin E Cybernetics, USA) software. The following parameters
(Roig Farma, Spain) per animal per day. At this time, were measured: lumen area circumscribed by the intima/
animals were subjected to catheterization and allowed to neointima lumina border; intima/neointima area between
recover by staying on each diet until sacrifice. Vascular the lumen and the internal elastic lamina; media area
injury was induced in the right internal iliac arteries, between internal and external elastic lamina; cell density,
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number of cells in 0.01 mm of the media; percentage 2.7.1. Semi-quantitative assessments
stenosis, defined as 1003(12lumen area / lumen area1 A visual grading scale for the assessment of the intensity
neointima area). of ISH and immunohistochemistry staining was performed
in batches of 12 slides and compared with internal control
2.6. In situ hybridization (ISH) sections (scored 0 and 3). Sections were characterized by
two observers independently, who were blinded to the
A 434-bp fragment (nucleotides 217–651) derived from characteristics of the samples. The mean scoring system of
human PAI-1 cDNA [26] was amplified by PCR and PAI-1 staining in relation to the number of cells / layer was
subcloned in the PGEM 3Z vector (Promega, USA). Sense established as follows: 0, no staining; 1, positive staining
and antisense probes were prepared by linearizing the ,25%; 2, positive staining .25%,75%; 3, positive
constructs with appropriate restriction enzymes and tran- staining .75%.
scribed with either T7 and SP6 RNA polymerase (Roche,
Switzerland) in the presence of DIG-11-UTP (Roche, 2.8. PAI-1 activity, cholesterol and vitamin E
Switzerland). ISH was performed according to Dijkman et measurements
al. [27], with some modifications. Arterial tissue sections
from animals were deparaffinized in xylene, rehydrated in Blood samples were collected in 0.13 mol / l sodium
ethanol, postfixated with paraformaldehyde for 10 min at citrate (9 /1, v /v) kept on ice for no longer than 2 h and the
48C and treated with proteinase K 10 mg/ml (30 min at platelet-poor plasma, obtained by centrifugation at 20003g
378C) (Roche, Switzerland). Samples were acetylated, for 20 min at 48C, was stored at 2708C until used.
washed and air dried. The cRNA probes were prepared at PAI-1 activity was measured by an amidolytic assay
the concentration of 2.5 ng/ml (in 50% formamide, SSC [30], using a commercially available kit (Coatest-PAI,
23 /dextran 10%, EDTA 5 mM, 10 mM DTT, 0.01% Chromogenix, Sweden). Assay specificity was assessed by
SDS, 13 Denhardt’s solution and 250 mg/ml salmon using serial dilutions of human t-PA (0–100 IU/ml).
sperm). Sections were covered with 20 ml of probe Serum cholesterol levels were determined by the stan-
solution, sealed with coverslips and left hybridizing over- dard enzymatic assay of Siedel et al. [31], using a fully
night, at 438C in a humidified chamber. Samples were automated clinical analyzer (Hitachi-717, Roche, Switzer-
washed with 50% formamide /23 SSC at 428C, 13 SSC at land).
RT and 0.53 SSC before immunological detection with Vitamin E was measured in plasma using a reverse-
anti-DIG antibody and X-Phosphate /NBT as substrate. phase high-performance liquid chromatography (HPLC)
The reaction was stopped 2 h after the addition of substrate method [32].
solution.
2.9. Statistical analysis
2.7. Immunohistochemistry
All data were expressed as mean6S.E.M. Comparisons
Sections were deparaffinized, rehydrated, and treated between different time periods within the same diet were
with 3% H O solution for 10 min to inhibit endogenous done by the Wilcoxon signed rank test. Differences2 2
peroxidase. Slides were covered with a solution containing between groups were calculated by analysis of variance
0.1% w/v trypsin (T-4799, Sigma, USA), 0.1% w/v (ANOVA) followed by Tukey posthoc test or by Kruska–
CaCl , 0.05 mol / l Tris–HCl, pH 7.6, for 10 min at 378C Wallis, for parametric and non-parametric conditions,2
[28]. Non-specific binding was blocked by incubation with respectively. Statistical significance was accepted at the
normal rabbit serum diluted 1:20 in TBS for 30 min and 95% confidence level (P,0.05). The correlation coeffi-
sections were incubated overnight at 48C with 100 mg/ml cient between variables was calculated using Spearman’s
anti-PAI-1 ([3785, American Diagnostica, USA) which correlation test for independent data. Histomorphological
recognizes inhibitor both free and complexed to plas- differences in response to vascular injury among groups
2
minogen activators. After washing with TBS, sections were assessed using x -test. Analysis was performed by
were incubated for 1 h in 1:200 biotinylated rabbit anti- using the computer program SPSS for Windows (SPSS,
mouse Fc (Dako, Denmark). Slides were treated for 1 h USA).
with the avidin–biotin–peroxidase complex (ABC, Dako,
Denmark) diluted 1:100. Peroxidase activity was detected
with 3-39-diaminobenzidine hydrochloride (Sigma, USA) 3. Results
and H O , with nickel enhancement, the time of develop-2 2
ment being the same for all samples [29]. Slides were 3.1. Hypercholesterolemia-induced vascular changes
counterstained with Harris’ hematoxylin, dehydrated and
mounted in DPX (BDH, UK). Negative controls (without 3.1.1. Morphometric analysis
primary antibody) yielded no immunohistochemical re- Hypercholesterolemic diet substantially increased plas-
action. ma cholesterol levels (1.560.1 in NC vs. 4.660.5 mM in
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HC, P,0.01) after 4 weeks of diet. Hematoxylin-eosin vascular PAI-1 was higher in HC than in NC group (25 vs.
staining of control arterial sections revealed intact endo- 6%).
thelial structure in all groups. The main morphological The plasma PAI-1 activity, which was similar in both
changes in the HC group as compared with NC group groups in baseline conditions, did not experience further
consisted of a significant increase in the percentage increase despite the cholesterol feeding (28.160.7 vs.
stenosis (14.763.3 vs. 5.760.3%, P,0.05) and intimal 28.660.2 AU/ml). Cholesterol rich diet did not induce
2
area (0.09 vs. 0.05 mm , P,0.01), as well as a significant significant changes in plasma vitamin E levels between HC
reduction in media cell density (38.867.9 vs. 47.363.9 and NC groups (1.760.2 vs. 2.060.4 mM, respectively).
2 210 cells /mm , P,0.05), without differences between
groups for other morphologic parameters analyzed. 3.2. Mechanical-induced vascular injury
3.2.1. Morphometric analysis
3.1.2. PAI-1 expression Angioplasty induced severe structural changes in the
An intense and extensive vascular PAI-1 positive signal vascular wall of both groups. A significant increase in the
in the media area was observed both by immunohisto- intimal area and percentage stenosis (P,0.05) was present
chemistry (Fig. 1A,B) and ISH (Fig. 1D,E) in the HC after vascular lesion as compared with non-injured arteries
group as compared with NC after 8 weeks of cholesterol in NC animals. Changes were evident at 7 days reaching
rich diet. Results regarding semiquantitative assessment of significance (P,0.05) 28 days after injury (Fig. 3A,B), but
immunohistochemistry and ISH in both groups are shown occurred earlier in the HC than in the NC group. A
in Fig. 2A,B. Increased PAI-1 expression was observed in significant (P,0.05) time-dependent increase in intimal
media layer of HC with respect to NC (P,0.01). Further- area, percentage stenosis and intima/media ratio was
more, the number of arteries that exhibited increased already observed 7 days after angioplasty and persisted
Fig. 1. Immunohistochemical and ISH patterns in vascular sections from hypercholesterolemic pigs. Panels A (NC), B (HC) and C (HCV) show the
immunohistochemical distribution of PAI-1 in uninjured iliac arteries after 8 weeks of diet. Panels D (NC), E (HC) and F (HCV) show the ISH pattern
corresponding to the same period. Panel E (magnification 320) also shows an adventitia section with scattered positive cells and strong positive signal in
vasa-vasorum endothelial cells (arrowhead). Representative score in the media area: F, 0; C and D, 1; A and E, 2; B, 3 (see text for explanations). Scale
bar51 mm.
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Fig. 2. Semiquantitative assessment of vascular PAI-1 by ISH (panels A and C) and immunohistochemistry (panels B and D) performed after 8 weeks of
diet in uninjured iliac arteries (A and B) and in sections taken 28 days after angioplasty (C and D). *P,0.05 and **P,0.01.
throughout the study (Fig. 3A,B,C). An increase in cell inhibitor activity was assayed at different time periods in
density was also observed 28 days after injury (Fig. 3C). both NC and HC groups. As shown in Fig. 5, a significant
The number of vessels with intimal thickening was higher increase of PAI-1 levels was observed 7 days after balloon
in this group (50% in NC vs. 87.5% in HC, P,0.01). injury in both NC (P,0.001) and HC (P,0.05) groups
with respect to baseline, still remaining elevated at 14 days
3.2.2. PAI-1 expression in the HC group (P,0.05).
Immunoreactive PAI-1 protein was abundantly present
in the thickened intima and in the media (Fig. 4A,B) in 3.3. Effect of vitamins C and E on PAI-1 expression
both NC and HC groups 14 days after vascular injury,
persisting after 4 weeks, although higher immunoreactivity Plasma vitamin E levels in the HCV group showed a
was observed at earlier times and more arteries were seven-fold increase with respect to HC group (14.163.6
involved in the HC group (62 vs. 31%). vs. 1.760.2 mM, P,0.001). The vitamin treatment did not
A strong ISH signal for PAI-1 mRNA was found in the influence significantly the cholesterol levels over the whole
deeper layers of the thickened intima in both NC and HC studied period, but it did have an effect on PAI-1 both in
groups, spreading out through the media up to the adven- uninjured and mechanically injured arteries.
titia layer (Fig. 4D,E). Changes started 7 days after injury
and were sustained during the 4-week period after angiop- 3.3.1. Uninjured arteries
lasty. As shown in Fig. 2C,D, stronger ISH and immuno- Vitamins C and E slightly reduced the intima/media
histochemistry signal for PAI-1 was observed in the intima ratio (0.260.1 vs. 0.0760.01) and percentage stenosis
(P,0.05 for the ISH score) and media (P,0.05) in the HC (23.563.9 vs. 14.763.3%) after 8 weeks of diet in HCV as
group 4 weeks after mechanical injury as compared with compared to HC groups (P,0.05). However, as shown in
NC. Fig. 1E,F, a weaker signal for vascular PAI in the media
To determine whether the above-mentioned changes and adventitia was observed in the HCV group and a
could influence circulating levels of PAI-1, the plasma significant reduction of protein in the media (P,0.05) and
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Fig. 3. Morphometric analysis of vascular sections after balloon injury in the different groups of animals. The intima area (A), percentage stenosis (B),
number of media cells (C) and intima/media ratio (D) in the balloon injured iliac arteries of NC, HC and HCV minipigs (n54) at the time animals were
sacrificed are shown. . *P,0.05 as compared to baseline samples, †P,0.05 as compared to NC group and ‡P,0.05 as compared to HC group.
mRNA expression in the adventitia (P,0.05) was demon- An interesting finding was the highly significant reduc-
strated in the HCV as compared with HC group at 8 weeks tion (P50.018) in the systemic PAI-1 activity in the HCV
(Fig. 2A,B). Moreover, the number of arteries in HCV group 28 days after balloon injury with respect to levels at
group with high PAI-1 expression was lower than in HC 14 days, reaching the values observed before vascular
animals (25 vs. 16%). In contrast, vitamins did not have lesion (Fig. 5).
any effect on plasma PAI-1 activity in the treated group
(28.660.2 vs. 27.560.2 AU/ml).
4. Discussion
3.3.2. Injured arteries
The vitamin treatment did not improve significantly the The main finding of the present study is that a combined
mechanical-induced structural changes in the vascular wall treatment of vitamins C and E attenuated the vascular
(Fig. 3B,C,D), but diminished (30% reduction, P,0.05) PAI-1 expression and significantly reduced the circulating
the mean intima area in relation to HC group (Fig. 3A). inhibitor levels induced by angioplasty in hypercholes-
Immunohistochemical and ISH patterns for vascular PAI-1 terolemic pigs, despite only trivial morphologic improve-
expression (Fig. 4C,F) as well as semiquantitative assess- ment in this experimental model of mild atherosclerosis.
ment (Fig. 2C, D) showed weaker PAI-1 expression in the Evidence is accumulating which indicates that abnormal
media layer in the HCV group as compared to HC (P,0.05 expression of the fibrinolytic system may promote the
for the ISH analysis), the score being similar to that development of atherosclerosis and play a role in the
observed in control animals. The number of arteries with remodeling process after vascular injury by influencing
high PAI-1 expression was also lower in HVC than in HC vascular SMC migration /proliferation and extracellular
group (41 vs. 62%). However, vitamins C and E were not matrix accumulation [8,14,18].
able to modify the intima PAI-1 vascular expression The pig model was chosen because of the similarities to
induced by hypercholesterolemic diet. the human coronary circulation, spontaneous development
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Fig. 4. Vascular PAI-1 expression after angioplasty in normal, hypercholesterolemic and vitamin-treated pigs. Immunohistochemistry (A,B,C) and ISH
(D,E,F) patterns in iliac arteries 28 days after angioplasty in NC (A,D), HC (B,E) and HCV (C,F) groups. A strong signal was observed after vascular
injury throughout the vessel wall with a marked attenuation in the HCV group. Semiquantitative score in the media area: D, 1; A,C,F, 2; B,E, 3 (see text for
explanations). Scale bar51 mm.
of atherosclerosis and histological response to vascular protein were significantly induced after injury as compared
injury [33]. with uninjured arteries, the expression being more intense
The present study shows that in the absence of me- in the area around the intimal thickening. Thus, vascular
chanical stress, hypercholesterolemic diet was associated injury elicits increased genetic expression of PAI-1 in
with some morphological changes in the vascular arteries several components in the induced lesions, which is
of miniature pigs, indicating a mild degree of athero- potentiated by hypercholesterolemia. The intramural PAI-1
sclerosis after 4 weeks of diet. These changes were related inhibition of proteolysis could play a role in the
associated with a homogeneous increase in vascular PAI-1 vascular remodeling process after vessel wall injury [11].
expression in the intima and media areas, as previously Moreover, circulating levels of PAI-1 were also enhanced
reported in different experimental models of hypercholes- after balloon injury, suggesting systemic inhibition of the
terolemia [28,34,35] and in human atherosclerotic plaques, fibrinolytic activity in response to injury [17,28,38].
suggesting a local involvement of this fibrinolysis inhibitor We, therefore, tried to assess whether vitamins C and E
[18,19,36,37]. Clinical and epidemiological studies have would be able to modify the PAI-1 expression induced by
also demonstrated that the elevation of PAI-1 levels is either hypercholesterolemic diet or after vascular injury.
common in several types of atherothrombosis [17,38]. Our results show that vitamin treatment, despite a mini-
Although the relationship between hypercholesterolemia mum effect on the morphologic parameters analyzed,
and thrombosis related to PAI-1 is presently unknown it is reduced the vascular PAI-1 expression induced by hy-
worthwhile pointing out that some cholesterol-lowering percholesterolemia and, to a lesser extent, the mechanically
drugs inhibited PAI-1, resulting in reduced thrombosis induced inhibitor expression. Oxidative stress is increas-
formation [39]. The combination of mechanical injury plus ingly being recognized as a potentially important con-
hypercholesterolemia was associated with a significant tributor to atherogenesis and restenosis after vascular
increase in the neointima formation and percentage intervention and injury [40,41]. The generation of reactive
stenosis, leading to intimal thickening. PAI-1 mRNA and oxygen species and oxidation of lipids have profound and
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proved to be beneficial to patients with atherosclerotic
disease [24].
Because the fibrinolytic system appears to play a
significant role in thrombosis and atherosclerosis, specific
modulators of the components of the fibrinolytic system
are promising targets for therapies of vascular disease. The
reported reduction of vessel-wall PAI-1 expression both in
injured and uninjured arteries of hypercholestrolemic
animal in response to vitamins C and E might represent
another step in the beneficial effect of antioxidants in
atherosclerotic disease [48].
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Fig. 5. Plasma PAI-1 activity in pigs after vascular injury. A significant
increase was observed in all groups 7 and 14 days after lesion in relation
to baseline, with recovery at 28 days especially in the vitamin-treated
group. Values are expressed as % of baseline. **P,0.001, *P,0.05 as References
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